Bayesian Adaptive Design for Immunotherapy and Targeted Therapy, 2023

Authors:

Language: English

147.69 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Bayesian Adaptive Design for Immunotherapy and Targeted Therapy
Publication date:
262 p. · 15.5x23.5 cm · Hardback

147.69 €

In Print (Delivery period: 15 days).

Add to cartAdd to cart
Bayesian Adaptive Design for Immunotherapy and Targeted Therapy
Publication date:
262 p. · 15.5x23.5 cm · Hardback

This book provides a comprehensive review of novel adaptive trial designs for targeted therapies and immunotherapies. This book covers a wide range of novel statistical designs for various clinical settings, including early phase dose-escalation study, proof-of-concept trials, and confirmatory studies with registrational. The book includes real-life examples and software to facilitate practitioners to learn and use the designs in practice.

Introduction to Adaptive Design and Delayed Outcomes.- Basics of Bayesian Statistics.- Phase I Dose-finding Design.- Phase II Design for Interim Monitoring.- Phase I-II Dose-finding Design.- Drug Combination Trial Design.- Conclusion.
The first book focusing on novel adaptive designs for targeted and immunotherapies Comprehensive coverage of state-of-the-art Bayesian adaptive designs, such as model-assisted designs Including many real-world trial examples